/ARGX
argenx SE
ARGX • NASDAQARGX • NASDAQ • Healthcare
$749.56+0.11%+0.84
$749.56+0.11%(+0.84)Healthcare
GoAI Score
Sign in to unlock
Valuation
50Fair Value
Sentiment
100Bullish
Risk
100Low Risk
Momentum
37Negative
Institutional-Grade Intelligence
🏆PRO
Actionable Intelligence
AI-driven stance, execution logic & risk thresholds
Catalyst Roadmap
Event timeline with expected impact & market context
Deep Insights
Fact-checked analysis & score logic breakdown
Financial Statements
Margin Trends
Gross
89.1%▼0.5pp
Revenue after COGS
Operating
23.4%▲24.3pp
After operating expenses
Net
31.1%▼6.9pp
Bottom-line profitability
Gross Margin
Operating Margin
Net Margin
Valuation Snapshot
P/E Ratio
39.8
Price vs earnings
EV/EBITDA
49.5
Enterprise value
FCF Yield
1.6%
Cash generation
Earnings Yield
2.5%
Inverse of P/E
Capital Efficiency
15
GoAI Quality ScoreFair
ROEReturn on Equity
17.7%Strong
ROAReturn on Assets
14.9%Strong
ROICReturn on Invested Capital
13.2%Strong
Financial Health
Current RatioHealthy
5.23
Short-term solvency (>1.5)
Net Debt / EBITDANet Cash
-3.50x
Debt repayment capacity (<3x)
Income QualityFair
0.66
Cash backs earnings (>1)
Revenue & Profitability
Revenue
Net Income
Net Loss
Income Statement
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $4.16B | $2.19B | $1.23B | $410.75M | $497.28M |
| Gross Profit | $3.71B | $1.96B | $1.11B | $381.31M | $497.28M |
| Gross Margin | 89.1% | 89.6% | 90.4% | 92.8% | 100.0% |
| Operating Income | $972.46M | -$21.65M | -$425.05M | -$720.34M | -$348.75M |
| Net Income | $1.30B | $833.04M | -$295.05M | -$709.59M | -$407.63M |
| Net Margin | 31.1% | 38.0% | -24.1% | -172.8% | -82.0% |
| EPS | $21.14 | $13.92 | -$5.16 | -$13.05 | -$7.99 |
Average Price Target
$1026.71▲ 37.0% Upside
Past 12 Months
12 Month Forecast
Based on 50 Wall Street analysts offering 12 month price targets for argenx SE, the average price target is $1026.71, with a high forecast of $1317.00 and a low forecast of $858.00. The average price target represents a 37.0% increase from the current price of $749.56.
Highest
$1317.00
Average
$1026.71
Lowest
$858.00
Rating Distribution
Strong Buy
1
3%
Buy
30
83%
Hold
5
14%
Sell
0
0%
Strong Sell
0
0%
Recent Analyst Ratings
FirmActionRatingDate
HC Wainwright & Co.● Maintain
Buy
2026-02-27Wells Fargo● Maintain
Overweight
2026-02-27Citizens● Maintain
Market Outperform
2026-02-27RBC Capital● Maintain
Outperform
2026-02-27Guggenheim● Maintain
Buy
2026-02-27Baird● Maintain
Neutral
2026-02-27Wells Fargo● Maintain
Overweight
2026-01-20Wedbush● Maintain
Outperform
2026-01-14Truist Securities● Maintain
Buy
2026-01-08Citigroup● Maintain
Buy
2026-01-08Earnings History & Surprises
BEAT RATE
69%
Last 13 quarters
AVG SURPRISE
+121.5%
EPS vs Estimate
BEATS / MISSES
9/4
Last 13 quarters
LATEST EPS
$5.18
Q4 '25
QUARTERLY EPS TREND
Estimated
Beat
Miss
QUARTERLY DETAIL
Q4 '25
+18.5%
$5.18 vs $4.37
Q2 '25
+163.3%
$2.58 vs $0.98
Q1 '25
No data
Q4 '24
+1290.0%
$1.39 vs $0.10
Q3 '24
No data
Q2 '24
-46.5%
$-1.04 vs $-0.71
Q1 '24
No data
Q4 '23
+15.5%
$-1.25 vs $-1.48
Q3 '23
No data
Q2 '23
No data
Q2 '23
+77.8%
$-0.52 vs $-2.34
Q4 '22
-21.7%
$-4.26 vs $-3.50
No investor questions available.
Latest News
No news available